ArticleVaccine2020
Enabling emergency mass vaccination: Innovations in manufacturing and administration during a pandemic.
Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Quality by design for mRNA platform purification based on continuous oligo-dT chromatography.Molecular therapy. Nucleic acids · 2024Article
- Epidemiological Evaluation of Events Allegedly Attributable to COVID-19 Vaccination: A Cross-Sectional Study in the Brazilian Amazon.Pharmaceuticals (Basel, Switzerland) · 2024Article
- Maximizing mRNA vaccine production with Bayesian optimization.Biotechnology and bioengineering · 2022Article
- Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.Vaccine · 2021Article
- How can we accelerate COVID-19 vaccine discovery?Expert opinion on drug discovery · 2021Article
- Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward.Human vaccines & immunotherapeutics · 2021Review
- COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology.International immunopharmacology · 2021Review
- Reactive mass vaccination campaign against cholera in the COVID-19 context in Cameroon: challenges, best practices and lessons learned.The Pan African medical journal · 2021Article
- Polymeric Nanoparticle-Based Vaccine Adjuvants and Delivery Vehicles.Current topics in microbiology and immunology · 2021Review
- A public health timeline to prepare for COVID-19 vaccines in Canada.Canadian journal of public health = Revue canadienne de sante publique · 2020Article
- Protecting the Herd: Why Pharmacists Matter in Mass Vaccination.Pharmacy (Basel, Switzerland) · 2020Review
- COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.Journal of virology · 2020Review
- Mass vaccination against COVID-19 may require replays of the polio vaccination drives.EClinicalMedicine · 2020Article
- The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be.Frontiers in plant science · 2020Review
- Primary Care's Historic Role in Vaccination and Potential Role in COVID-19 Immunization Programs.Annals of family medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.